Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis

Introduction and objectives: Non-alcoholic fatty liver disease (NAFLD) is multistage with heterogeneous outcomes. We studied the influence of insulin resistance (IR) on the hepatic transcriptome of early NAFLD stages, to understand disease development. Materials and methods: In this cross-sectional...

Full description

Bibliographic Details
Main Authors: Ankita Chatterjee, Analabha Basu, Kausik Das, Pankaj Singh, Dipankar Mondal, Biswanath Bhattacharya, Shweta Roychoudhury, Partha P. Majumder, Abhijit Chowdhury, Priyadarshi Basu
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268120300703
_version_ 1818837381418057728
author Ankita Chatterjee
Analabha Basu
Kausik Das
Pankaj Singh
Dipankar Mondal
Biswanath Bhattacharya
Shweta Roychoudhury
Partha P. Majumder
Abhijit Chowdhury
Priyadarshi Basu
author_facet Ankita Chatterjee
Analabha Basu
Kausik Das
Pankaj Singh
Dipankar Mondal
Biswanath Bhattacharya
Shweta Roychoudhury
Partha P. Majumder
Abhijit Chowdhury
Priyadarshi Basu
author_sort Ankita Chatterjee
collection DOAJ
description Introduction and objectives: Non-alcoholic fatty liver disease (NAFLD) is multistage with heterogeneous outcomes. We studied the influence of insulin resistance (IR) on the hepatic transcriptome of early NAFLD stages, to understand disease development. Materials and methods: In this cross-sectional study, possible clinicopathological risk factors were compared between mild-NAFL (N = 72) and non-alcoholic steatohepatitis (NASH; N = 51) patients. Liver tissue-transcriptome difference was studied between a subset of 25 mild-NAFL and 20 NASH biopsies and validated on another subset of 12 mild-NAFL and 13 NASH biopsies, using RT-PCR. The relationship between IR driven gene expression changes with fibrosis in NASH was investigated. Results: Significantly higher weight (p = 0.005) and elevated levels of HbA1c (p = 0.009), FBG (p = 0.03) and HOMA-IR (p = 0.009) were found in NASH patients. Five differentially expressed genes (DEGs, fold change > 1.5) were identified in NASH-FABP4, FABP5L2, CD24, PRAP1, and SPP1. The DEGs were positively associated with disease severity and HOMA-IR, and were found to be efficient classifiers of mild-NAFL and NASH. Additional 1218 genes identified related to IR (IrCGs), which can classify NASH-with-fibrosis patients separately from mild-NAFL and NASH patients. IrCGs can promote intra-hepatic fat accumulation, dysregulation of the lipid metabolism, lipotoxicity, and activation of cell survival pathways including activation of cell proliferation and differentiation pathways. Conclusions: Hepatic expression of genes associated with insulin resistance may drive NAFLD development and progression.
first_indexed 2024-12-19T03:21:36Z
format Article
id doaj.art-57b57b177f66460ea041a797552cc702
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-19T03:21:36Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-57b57b177f66460ea041a797552cc7022022-12-21T20:37:45ZengElsevierAnnals of Hepatology1665-26812020-09-01195472481Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesisAnkita Chatterjee0Analabha Basu1Kausik Das2Pankaj Singh3Dipankar Mondal4Biswanath Bhattacharya5Shweta Roychoudhury6Partha P. Majumder7Abhijit Chowdhury8Priyadarshi Basu9National Institute of Biomedical Genomics, Kalyani, West Bengal, IndiaNational Institute of Biomedical Genomics, Kalyani, West Bengal, IndiaInstitute of Post Graduate Medical Education and Research, Kolkata, West Bengal, IndiaInstitute of Post Graduate Medical Education and Research, Kolkata, West Bengal, IndiaInstitute of Post Graduate Medical Education and Research, Kolkata, West Bengal, IndiaNational Institute of Biomedical Genomics, Kalyani, West Bengal, IndiaNational Institute of Biomedical Genomics, Kalyani, West Bengal, IndiaNational Institute of Biomedical Genomics, Kalyani, West Bengal, IndiaInstitute of Post Graduate Medical Education and Research, Kolkata, West Bengal, IndiaNational Institute of Biomedical Genomics, Kalyani, West Bengal, India; Corresponding author.Introduction and objectives: Non-alcoholic fatty liver disease (NAFLD) is multistage with heterogeneous outcomes. We studied the influence of insulin resistance (IR) on the hepatic transcriptome of early NAFLD stages, to understand disease development. Materials and methods: In this cross-sectional study, possible clinicopathological risk factors were compared between mild-NAFL (N = 72) and non-alcoholic steatohepatitis (NASH; N = 51) patients. Liver tissue-transcriptome difference was studied between a subset of 25 mild-NAFL and 20 NASH biopsies and validated on another subset of 12 mild-NAFL and 13 NASH biopsies, using RT-PCR. The relationship between IR driven gene expression changes with fibrosis in NASH was investigated. Results: Significantly higher weight (p = 0.005) and elevated levels of HbA1c (p = 0.009), FBG (p = 0.03) and HOMA-IR (p = 0.009) were found in NASH patients. Five differentially expressed genes (DEGs, fold change > 1.5) were identified in NASH-FABP4, FABP5L2, CD24, PRAP1, and SPP1. The DEGs were positively associated with disease severity and HOMA-IR, and were found to be efficient classifiers of mild-NAFL and NASH. Additional 1218 genes identified related to IR (IrCGs), which can classify NASH-with-fibrosis patients separately from mild-NAFL and NASH patients. IrCGs can promote intra-hepatic fat accumulation, dysregulation of the lipid metabolism, lipotoxicity, and activation of cell survival pathways including activation of cell proliferation and differentiation pathways. Conclusions: Hepatic expression of genes associated with insulin resistance may drive NAFLD development and progression.http://www.sciencedirect.com/science/article/pii/S1665268120300703TranscriptomeNASHInsulin-resistanceFibrosisHOMA-IR
spellingShingle Ankita Chatterjee
Analabha Basu
Kausik Das
Pankaj Singh
Dipankar Mondal
Biswanath Bhattacharya
Shweta Roychoudhury
Partha P. Majumder
Abhijit Chowdhury
Priyadarshi Basu
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
Annals of Hepatology
Transcriptome
NASH
Insulin-resistance
Fibrosis
HOMA-IR
title Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
title_full Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
title_fullStr Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
title_full_unstemmed Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
title_short Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
title_sort hepatic transcriptome signature correlated with homa ir explains early nonalcoholic fatty liver disease pathogenesis
topic Transcriptome
NASH
Insulin-resistance
Fibrosis
HOMA-IR
url http://www.sciencedirect.com/science/article/pii/S1665268120300703
work_keys_str_mv AT ankitachatterjee hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT analabhabasu hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT kausikdas hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT pankajsingh hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT dipankarmondal hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT biswanathbhattacharya hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT shwetaroychoudhury hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT parthapmajumder hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT abhijitchowdhury hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis
AT priyadarshibasu hepatictranscriptomesignaturecorrelatedwithhomairexplainsearlynonalcoholicfattyliverdiseasepathogenesis